Corbus Pharmaceuticals Holdings Inc

Healthcare
$28.00
+1.93(7.40%) 1D
1D
1W
1M
1Y
3Y
5Y

Performance

Open PricePrev. CloseVolumeAvg. Volume
$25.61$26.07140,7171,696,739

Fundamentals

Market Cap$123.90M
P/B Ratio398.4
P/E Ratio-2.6
Enterprise Value$134.80M
Div. Yield0.00%
Book Value0.07
EPS(TTM)-2.27
ROENA
Understand Fundamentals

About the Company

Corbus Pharmaceuticals (CRBP) is a clinical-stage pharmaceutical business dedicated to the discovery and commercialization of new medicines for the treatment of uncommon, chronic, and severe inflammatory and fibrotic illnesses with significant unmet medical needs. Anabasum is a new synthetic oral endocannabinoid-mimetic medication that is designed to cure chronic inflammation and stop fibrotic processes without inducing immunosuppression. Anabasum is being developed to treat four potentially fatal diseases: systemic sclerosis, cystic fibrosis, diffuse cutaneous, skin-predominant dermatomyositis, and systemic lupus erythematosus ("SLE"). The FDA of the US has given anabasum Orphan Designation and Fast Track Status for cystic fibrosis and systemic sclerosis.;
OrganisationCorbus Pharmaceuticals Holdings Inc

Company Financials

*All values are in Million $
No Graph Data To Display
Quarterly
Yearly

Similar Stocks

COMPANYMARKET PRICECLOSE PRICEMARKET CAP
Invest the way you want
Join millions of Indians who trust and love Groww
Explore Products
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.7.6
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK MAHINDRA |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  BANDHAN |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  IDBI |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ |  BAJAJ